Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent

James Ellis1, John D Pediani, Meritxell Canals

  • 1Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, United Kingdom.

Insights

Ligands can alter the function of unrelated receptors by targeting receptor heterodimers. This novel mechanism was observed with orexin-1 and cannabinoid CB1 receptors, impacting cellular signaling pathways.

Area of Science:

  • Neuropharmacology
  • Cell Biology
  • Receptor Signaling

Background:

  • The human orexin-1 receptor (OX1R) and cannabinoid CB1 receptor (CB1R) are G protein-coupled receptors involved in various physiological processes.
  • Receptor trafficking and internalization are critical for regulating cellular responses to stimuli.
  • Heterodimerization between different receptor types can influence their individual signaling properties.

Purpose of the Study:

  • To investigate the interaction and functional consequences of co-expressing OX1R and CB1R in HEK293 cells.
  • To explore the role of receptor heterodimerization in ligand-induced and spontaneous receptor trafficking.
  • To determine if ligands targeting one receptor can modulate the function of a co-expressed, unrelated receptor.

Main Methods:

  • Inducible and constitutive expression of OX1R and CB1R in HEK293 cells.
  • Confocal microscopy and single-cell fluorescence resonance energy transfer (FRET) imaging to assess receptor localization and heterodimerization.
  • Pharmacological treatments with receptor agonists and antagonists (SR-141716A for CB1R, SB-674042 for OX1R).
  • Measurement of mitogen-activated protein kinase (MAPK) pathway activation (ERK1/2 phosphorylation) to assess receptor function.

Main Results:

  • Constitutive CB1R expression led to spontaneous internalization, while OX1R showed agonist-induced internalization.
  • Co-expression of OX1R and CB1R resulted in both receptors exhibiting spontaneous internalization, forming intracellular heterodimers/oligomers.
  • Antagonists for one receptor (SR-141716A or SB-674042) induced cell surface re-localization of both co-expressed receptors.
  • Ligands targeting one receptor altered the potency of the other receptor's agonist in activating ERK1/2 signaling specifically in co-expressing cells.

Conclusions:

  • OX1R and CB1R form functional heterodimers that influence each other's trafficking and signaling.
  • Ligands can indirectly modulate the function of unrelated receptors through their action on receptor heterodimers.
  • This study reveals a novel pharmacological paradigm where receptor heterodimerization mediates cross-talk between distinct receptor systems.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...